Design of Nanocarriers for Chemotherapy of Prostate Cancer

Abstract

Any part of the body might become cancerous. It begins when regular cells are pushed out by out-of-control cells. This can spread to other parts of the body and interfere with normal bodily functions. Globally, cancer is considered to be a huge burden that will only get worse as the population ages and grows. Given the various drawbacks and adverse effects of the traditional formulations, novel strategies for medication delivery to prostate cancer cells are being researched and explored. With their many advantages over traditional chemotherapy, including improved drug solubility, protection from macrophage uptake, which lengthens the drug's blood residence time, and controlled drug delivery to the target prostate cancer, polymeric nanoparticles have been identified as promising candidates for drug delivery to prostate cancer.